Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation

Multiple Myeloma Clinical Trial

Official title:

Effect of the Use of a Cycloergometer on the Physical Performance of Patients Undergoing Hematopoietic Stem Cell Transplantation: A Randomized and Controlled Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04496011
• Other study ID #: TMO 2020
• Status: Recruiting
• Phase: N/A
• Start date: March 2, 2020
• Est. completion date: December 2020

Study information

• Verified date: July 2020
• Source: Federal University of Health Science of Porto Alegre
• Contact: Fabricio Edler Macagnan, PhD
• Phone: +55 (51) 3309.8876
• Email: fabriciom[@]ufcspa.edu.br
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Physiological changes caused by hematological diseases associated with high dose chemotherapy have a negative impact on patient's functionality, making them more fragile and vulnerable after hematopoietic cell transplantation. Currently, randomized studies have shown that physical exercise can contribute to improve Quality of Life of these patients. In this randomized controlled trial, we will study the effect of using the bicycle ergometer on the physical performance of patients undergoing transplantation of hematopoietic stem cells (HSCT).

Description:

The sample consists of 30 patients diagnosed with leukemia, lymphoma and multiple myeloma, undergoing high-dose chemotherapy and hematopoietic stem cells transplantation, who will be randomized into two groups. The results of muscle strength in the lower limbs, general mobility, fatigue and clinical symptoms will be compared between the control group and the experimental group.

The control group will perform an exercise program based on the standard protocol of the physiotherapy service, where exercises are performed to gain strength in muscle groups of the upper and lower limbs, range of motion, balance and functional movements. The experimental group will perform the same exercises as the control group, added to a training program using a bicycle ergometer, with an incremental load (from 60% to 70% of the maximum heart rate) for 20 minutes.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: December 2020
• Est. primary completion date: September 30, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• Adult patients (18-70 years) scheduled to perform the first HSCT;

• Be with a preserved neurological function and full cognition;

• Have clinical conditions that allow participation in the motor physiotherapy program;

• Be agreed with a study proposal and sign the free and informed consent form (ICF).

Exclusion Criteria:

• Develop clinical complications that contraindicate the performance of motor physiotherapy including the practice of the cycle ergometer;

• Present a previous musculoskeletal alteration that interferes with the performance of physical performance assessment tests;

• Recent cardiovascular or pulmonary disease;

• Psychiatric or neurological disorder;

• Need for gait assistance or presence of bone metastasis

• Adherence below 50% of the total motor physiotherapy protocol.

Related Conditions & MeSH terms

• Fatigue
• Hematopoietic Stem Cell Transplantation
• Leukemia
• Lymphoma
• Multiple Myeloma

Intervention

Other:
• Aerobic training with cycle ergometer
Patients start with an initial warm-up of 2 minutes, with rotations per minute free, without load. Progressively, the load of the exercise cycle increases every minute up to the supported limit or up to 60% - 70% of maximum heart rate (HRmax). The training will be carried out for 20 continuous minutes, being interrupted whenever the heart rate (HR) reaches 90% of the maximum expected for the age and / or the loss of effort perceived in the BORG scale, above 8 on a scale of 0 to 10.

Locations

Country	Name	City	State
Brazil	Universidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA	Porto Alegre	RS

Sponsors (1)

Lead Sponsor	Collaborator
Federal University of Health Science of Porto Alegre

Country where clinical trial is conducted

Brazil, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Lower Limb Physical Functioning and Strength	The 30-Second Chair Stand evaluates lower limb strength and, indirectly, the risk of falls, especially in the elderly population (JONES, J., RIKLI, 2002). This way, it will compose the set of tests used to determine the physical performance by measuring the number of stands from an armless chair of standard height (45 cm) performed in 30 seconds. The test will be begin when the participant, seating on a neutral spine position and feet flat on the floor, will be instructed to rise to a full stand and return to the original seated position, as quickly as possible. The participant will be instructed to move at maximal speed until they either feel the need to stop or the 30-second time limit is reached. More than 8 unassisted stands for men and women are considered above average for their age, and those below the range as below average	Trough study completion, an average of 2 months
Secondary	Fatigue	Piper Fatigue Scale, developed by Piper et al. (1998), is a multidimensional measure of fatigue in the field of cancer research and includes subdomains of the behavioral, affective, sensorial and cognitive attributes / fatigue mood, composed of 22 items. The scores for each item range from 0 to 10 and can total 220 points. Higher values characterize a greater perception of fatigue. It will be applied on patient's evaluation day and on hospital discharge day.	Trough study completion, an average of 2 months
Secondary	Symptoms Assessment	The Edmonton Symptom Assessment Scalemorning will be applied to eavaluate symptoms of pain, tiredness, drowsiness, appetite, nausea, shortness of breath, depression, anxiety and well-being. It is a scale where the patient provides an auto-report on a score that can vary from 0 to 10, being score 0 absence of symptoms and 10 represents the most intense sensation experienced by the patient.	Trough study completion, an average of 2 months
Secondary	Timed up and Go (TUG)	TUG is used in clinical practice to assess mobility, the risk of falls and also to assist in the diagnosis of sarcopenia. For this reason, that test will be compiled or set of tests that will be used to determine physical performance.	Trough study completion, an average of 2 months